These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9344339)

  • 41. Measles serodiagnosis: standardization and evaluation of a Dot-ELISA.
    Vaz De Lima LR; Hoshino-Shimizu S; de Souza VA; Pannuti CS; Andrade Júnior HF; Sumita LM; Ferreira AW
    Rev Inst Med Trop Sao Paulo; 1994; 36(2):139-47. PubMed ID: 7997789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of São Paulo, Brazil, 2000-2004.
    Ciccone FH; Carvalhanas TR; Afonso AM; Flannery B; Waldman EA
    Rev Soc Bras Med Trop; 2010; 43(3):234-9. PubMed ID: 20563487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonclassic measles infections in an immune population exposed to measles during a college bus trip.
    Helfand RF; Kim DK; Gary HE; Edwards GL; Bisson GP; Papania MJ; Heath JL; Schaff DL; Bellini WJ; Redd SC; Anderson LJ
    J Med Virol; 1998 Dec; 56(4):337-41. PubMed ID: 9829639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
    Saika S; Matsunaga T; Ogawa T; Ichinohe S
    Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.
    Pedersen IR; Mordhorst CH; Ewald T; von Magnus H
    Vaccine; 1986 Sep; 4(3):173-8. PubMed ID: 3532604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Short communication: The sensitivity of measles diagnosis by physicians and families during an intraepidemic period in Edirne: implications for measles surveillance].
    Eskiocak M; Ekuklu G; Doğaner E; Yilmaz N; Saltik A
    Mikrobiyol Bul; 2008 Jan; 42(1):143-8. PubMed ID: 18444573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological findings during a measles outbreak occurring in a population with high vaccine coverage.
    Oliveira SA; Siqueira MM; Costa AJ; Almeida MT; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):421-5. PubMed ID: 8729752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HHV-6 IgG4 isotype response following measles infection.
    Ferreyra L; Bustos D; Biganzoli P; Isa MB; Don PS; Ribechini E; Nates SV; Pavan JV
    J Med Virol; 2010 Mar; 82(3):396-9. PubMed ID: 20087929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two cases of mild IgM-negative measles in previously vaccinated adults, the Netherlands, April and July 2011.
    van den Hoek A; Sonder GJ; Scholing M; Gijselaar D; van Binnendijk RS
    Euro Surveill; 2011 Dec; 16(48):. PubMed ID: 22172302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia.
    Khalil MK; Nadrah HM; Al Yahia OA; ElGhazali G
    East Mediterr Health J; 2011 Mar; 17(3):191-5. PubMed ID: 21735958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental measles. II. Infection and immunity in the rhesus macaque.
    Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
    Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles virus-specific immunoglobulin G isotype immune response in early and late infections.
    Isa MB; Martínez L; Giordano M; Zapata M; Passeggi C; De Wolff MC; Nates S
    J Clin Microbiol; 2001 Jan; 39(1):170-4. PubMed ID: 11136766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a commercial ELISA for the detection of measles-specific immunoglobulin G (IgG) in dried blood spots collected from children living in low-resource settings.
    Colson KE; Potter A; Conde-Glez C; Hernandez B; Ríos-Zertuche D; Zúñiga-Brenes P; ; Iriarte E; Mokdad AH
    J Med Virol; 2015 Sep; 87(9):1491-9. PubMed ID: 25988945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
    Rosen JB; Rota JS; Hickman CJ; Sowers SB; Mercader S; Rota PA; Bellini WJ; Huang AJ; Doll MK; Zucker JR; Zimmerman CM
    Clin Infect Dis; 2014 May; 58(9):1205-10. PubMed ID: 24585562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.